Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
出版年份 2017 全文链接
标题
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 10, Pages 1131-1136
出版商
Informa UK Limited
发表日期
2017-08-18
DOI
10.1080/13543784.2017.1369527
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
- (2017) Clifford R Jack et al. LANCET NEUROLOGY
- Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data
- (2017) Charles C. White et al. PLOS MEDICINE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
- (2014) Patty Kandalepas et al. Current Alzheimer Research
- Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models
- (2014) Irina Lonskaya et al. Molecular Neurodegeneration
- Comparable brain levels of amyloid-β and tau in asymptomatic AD and mild cognitive impairment
- (2014) Nature Reviews Neurology
- Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
- (2014) Katherine R. Sadleir et al. PLoS One
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
- (2013) Patty C. Kandalepas et al. ACTA NEUROPATHOLOGICA
- Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles
- (2013) Cyril Cheret et al. EMBO JOURNAL
- Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of β Site Amyloid Precursor Protein-cleaving Enzyme 1
- (2013) Minzi Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blood–brain-barriers in aging and in Alzheimer’s disease
- (2013) Fernanda Marques et al. Molecular Neurodegeneration
- BACE1 Regulates Hippocampal Astrogenesis via the Jagged1-Notch Pathway
- (2013) Xiangyou Hu et al. Cell Reports
- The Genetics of Alzheimer Disease
- (2013) R. E. Tanzi Cold Spring Harbor Perspectives in Medicine
- Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study
- (2012) Claudia H. Kawas et al. Alzheimers & Dementia
- Origins of Alzheimerʼs disease
- (2012) Erik S. Musiek et al. CURRENT OPINION IN NEUROLOGY
- β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
- (2012) Jun Cai et al. EMBO Molecular Medicine
- Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
- (2012) Gary Probst et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism
- (2012) Katherine R. Sadleir et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
- (2012) Brian Hitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
- (2012) Yonghao Zhao et al. Molecular Neurodegeneration
- BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease
- (2012) Linda Chami et al. Molecular Neurodegeneration
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia
- (2012) A. B. Balasubramanian et al. NEUROLOGY
- Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
- (2012) Inna Rabinovich-Nikitin et al. PLoS One
- Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play
- (2012) Clifford R. Jack RADIOLOGY
- The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease
- (2012) Luxiang Cao et al. Scientific Reports
- Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
- (2011) John L. Robinson et al. BRAIN
- Inhibition of β-Secretasein Vivovia Antibody Binding to Unique Loops (D and F) of BACE1
- (2011) Lujia Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
- (2011) Tharinda W Rajapaksha et al. Molecular Neurodegeneration
- A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid- Production in Vivo
- (2011) J. K. Atwal et al. Science Translational Medicine
- Alzheimer's Disease: The Challenge of the Second Century
- (2011) D. M. Holtzman et al. Science Translational Medicine
- β-Amyloid1–42Gene Transfer Model Exhibits Intraneuronal Amyloid, Gliosis, Tau Phosphorylation, and Neuronal Loss
- (2010) G. William Rebeck et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic Causes of Frontotemporal Degeneration
- (2010) Tricia M. See et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP
- (2010) Shanta Boddapati et al. JOURNAL OF MOLECULAR BIOLOGY
- BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
- (2010) X. Hu et al. JOURNAL OF NEUROSCIENCE
- BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization
- (2010) Brian D. Hitt et al. Molecular Neurodegeneration
- An Amyloid-Notch Hypothesis for Alzheimer’s Disease
- (2010) Douglas W. Ethell NEUROSCIENTIST
- Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport: Fig. 1
- (2010) Keith A. Vossel et al. SCIENCE
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
- (2008) Xiangyou Hu et al. FASEB JOURNAL
- Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice
- (2008) A. V. Savonenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer's disease
- (2007) Dione Kobayashi et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now